FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,354,000 | -23.1% | 893,580 | -16.4% | 0.85% | -12.8% |
| Q1 2021 | $9,564,000 | -22.4% | 1,068,580 | 0.0% | 0.98% | -26.8% |
| Q4 2020 | $12,331,000 | +10.9% | 1,068,580 | 0.0% | 1.33% | +6.8% |
| Q3 2020 | $11,124,000 | -27.7% | 1,068,580 | -8.7% | 1.25% | -10.8% |
| Q2 2020 | $15,384,000 | +119.7% | 1,169,895 | +31.5% | 1.40% | +9.2% |
| Q1 2020 | $7,001,000 | -65.6% | 889,578 | -9.6% | 1.28% | -58.2% |
| Q4 2019 | $20,367,000 | +51.0% | 983,924 | 0.0% | 3.07% | +92.6% |
| Q3 2019 | $13,485,000 | +18.0% | 983,924 | +5.9% | 1.59% | +41.9% |
| Q2 2019 | $11,426,000 | +3.6% | 928,924 | +5.1% | 1.12% | -23.9% |
| Q1 2019 | $11,033,000 | +66.9% | 884,018 | +51.4% | 1.48% | +47.9% |
| Q4 2018 | $6,611,000 | -47.6% | 584,018 | -13.4% | 1.00% | +13.2% |
| Q3 2018 | $12,620,000 | -55.2% | 674,483 | -38.1% | 0.88% | -55.2% |
| Q2 2018 | $28,156,000 | +27.0% | 1,089,220 | +10.1% | 1.96% | +12.2% |
| Q1 2018 | $22,168,000 | -0.1% | 989,220 | +11.6% | 1.75% | +22.4% |
| Q4 2017 | $22,191,000 | -11.2% | 886,220 | -14.2% | 1.43% | -12.1% |
| Q3 2017 | $24,986,000 | +29.5% | 1,033,321 | +8.3% | 1.63% | +23.5% |
| Q2 2017 | $19,287,000 | -37.5% | 953,869 | -16.8% | 1.32% | -22.2% |
| Q1 2017 | $30,854,000 | +17.6% | 1,146,551 | -16.9% | 1.70% | +33.6% |
| Q4 2016 | $26,238,000 | +25.8% | 1,379,486 | +29.2% | 1.27% | +32.7% |
| Q3 2016 | $20,861,000 | +27.0% | 1,067,621 | -2.7% | 0.96% | +5.9% |
| Q2 2016 | $16,424,000 | +170.3% | 1,097,463 | +66.2% | 0.90% | +170.4% |
| Q1 2016 | $6,076,000 | -59.0% | 660,463 | -14.2% | 0.33% | -53.7% |
| Q4 2015 | $14,836,000 | +19.5% | 769,903 | -7.9% | 0.72% | +20.4% |
| Q3 2015 | $12,419,000 | -46.9% | 835,725 | -21.8% | 0.60% | -34.5% |
| Q2 2015 | $23,382,000 | +0.6% | 1,068,140 | +3.5% | 0.91% | -7.2% |
| Q1 2015 | $23,233,000 | +10.9% | 1,031,640 | -0.6% | 0.98% | +8.2% |
| Q4 2014 | $20,947,000 | +100.1% | 1,037,489 | +80.9% | 0.91% | +93.6% |
| Q3 2014 | $10,469,000 | +51.5% | 573,357 | +11.4% | 0.47% | +77.4% |
| Q2 2014 | $6,909,000 | +4.8% | 514,466 | +28.3% | 0.26% | -21.4% |
| Q1 2014 | $6,591,000 | – | 400,900 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
| MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
| Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
| Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
| Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
| SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
| AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
| Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |